Track the 퓨쳐켐 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 퓨쳐켐 has logged 41 insider filings. Market capitalisation: €205.6bn. The latest transaction was disclosed on 22 June 2026 (Other). Among the most active insiders: 길희섭. The full history is openly available.
41
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
25 ops.
Sell Volume
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 24,574 of 26,372 companies
18.3
score / 100
Value
21
Quality
16
FCF yld-5.3%
Earn yld-5.4%
EV/EBITDA·
ROE-19%
Gross mgn23%
Net mgn-60%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
퓨쳐켐 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for medical diagnosis and treatment.